Immuneel Therapeutics Secures ₹100 Crore in Series B Funding Round
Cancer-focused biotech Immuneel Therapeutics raised over Rs 100 crore in Series B funding for expansion.
Read moreDetailsADVERTISEMENT
Tag: Immuneel Therapeutics
© 2026 StartupSuperb - Latest Indian Startup News StartupSuperb.